New drug approved for duchenne muscular dystrophy

The U.S. Food and Drug Administration approved a drug for all patients with child onset muscular dystrophy, serving as the first of its kind.

 Maria Kaloudi

The U.S. Food and Drug Administration approved a drug for all patients with child onset muscular dystrophy, the second drug approved for the disease and the first for everyone with the disorder. (Chicago Tribune)